{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:21:19Z","timestamp":1792419679358,"version":"4.5.0"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,15]]},"DOI":"10.18632\/oncotarget.19800","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T02:50:20Z","timestamp":1501642220000},"page":"68627-68640","source":"Crossref","is-referenced-by-count":25,"title":["Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Anna","family":"Truini","sequence":"first","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"},{"name":"Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Coco","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Nadal","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain"},{"name":"Molecular Mechanisms and Experimental Therapeutics Program, Bellvitge Biomedical Research Institute (IDIBELL), L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Section of Thoracic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Genova","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"},{"name":"Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Dal Bello","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Vanni","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Alama","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Rijavec","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Biello","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Barletta","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Franco","family":"Merlo","sequence":"additional","affiliation":[{"name":"Research and Statistics Infrastructure, Azienda Unit\u00e0 Sanitaria Locale di Reggio Emilia - IRCCS, Institute for Advanced Technologies and HealthCare Protocols in Oncology, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Valentino","sequence":"additional","affiliation":[{"name":"Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ferro","sequence":"additional","affiliation":[{"name":"Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Ravetti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stigliani","sequence":"additional","affiliation":[{"name":"UOS Physiopathology of Human Reproduction, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vigani","sequence":"additional","affiliation":[{"name":"Division of Oncology, ASL5, La Spezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Fedeli","sequence":"additional","affiliation":[{"name":"Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Beer","sequence":"additional","affiliation":[{"name":"Section of Thoracic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Roncella","sequence":"additional","affiliation":[{"name":"Division of Histopathology and Cytopathology, ASL5, La Spezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grossi","sequence":"additional","affiliation":[{"name":"Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Lake","year":"2005","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/bjc.2012.245","article-title":"Prognosis and prognostic factors of patients with mesothelioma: a population-based study","volume":"107","author":"Moons","year":"2012","journal-title":"Br J Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/14656566.2016.1176145","article-title":"Advances in treatment of mesothelioma","volume":"17","author":"Grossi","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"4","unstructured":"Lim. MARS 2: A Feasibility Study Comparing (Extended) Pleurectomy Decortication Versus no Pleurectomy Decortication in Patients With Malignant Pleural Mesothelioma (MARS2) NCT02040272. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02040272 Date last updated: April 12 2016. Date last accessed: December 5 2016."},{"key":"5","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Gervais","year":"2016","journal-title":"Lancet"},{"key":"7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis","volume":"48","author":"Knuutila","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs dysregulation in human malignant pleural mesothelioma","volume":"6","author":"Tognon","year":"2011","journal-title":"J Thorac Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Goren","year":"2010","journal-title":"J Mol Diagn"},{"key":"10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Gaudino","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Marsit","year":"2010","journal-title":"Int J Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Aharonov","year":"2010","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Reid","year":"2015","journal-title":"Mol Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa060096","article-title":"A five-gene signature and clinical outcome in non-small-cell lung cancer","volume":"356","author":"Liu","year":"2007","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"18713","DOI":"10.18632\/oncotarget.7666","article-title":"microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma","volume":"7","author":"Mairinger","year":"2016","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/gcc.20582","article-title":"Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer","volume":"47","author":"Takahashi","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.oraloncology.2012.02.020","article-title":"Downregulation of the microRNA-99 family members in head and neck squamous cell carcinoma","volume":"48","author":"Zhou","year":"2012","journal-title":"Oral Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3892\/ol.2013.1473","article-title":"miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2","volume":"6","author":"Xie","year":"2013","journal-title":"Oncol Lett"},{"key":"19","first-page":"10","article-title":"A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21","volume":"6","author":"Climent","year":"2015","journal-title":"Front Physiol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3892\/mmr.2014.2792","article-title":"microRNA-99a inhibits cell proliferation, colony formation ability, migration and invasion by targeting fibroblast growth factor receptor 3 in prostate cancer","volume":"11","author":"Zhou","year":"2015","journal-title":"Mol Med Rep"},{"key":"21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1074\/jbc.M111.278705","article-title":"MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells","volume":"287","author":"Gao","year":"2012","journal-title":"J Biol Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Slack","year":"2005","journal-title":"Cell"},{"key":"23","doi-asserted-by":"crossref","first-page":"e102403","DOI":"10.1371\/journal.pone.0102403","article-title":"MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma","volume":"9","author":"Yen","year":"2014","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000445642","article-title":"MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein","volume":"39","author":"Xu","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"25","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/onc.2013.77","article-title":"Regulation of several androgen-induced genes through the repression of the miR-99a\/let-7c\/miR-125b-2 miRNA cluster in prostate cancer cells","volume":"33","author":"Dutta","year":"2014","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1038\/onc.2015.396","article-title":"Genome-wide screen identified let-7c\/miR-99a\/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma","volume":"35","author":"Chen","year":"2016","journal-title":"Oncogene"},{"key":"27","first-page":"516","article-title":"Inflammation in malignant mesothelioma - friend or foe?","volume":"1","author":"Kao","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"28","first-page":"55","article-title":"The role of interleukin-6 in malignant mesothelioma","volume":"4","author":"Coward","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc3355","article-title":"Tumorigenesis in Down's syndrome: big lessons from a small chromosome","volume":"12","author":"Groet","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00018-014-1584-5","article-title":"Role of microRNAs in malignant mesothelioma","volume":"71","author":"Grossi","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/2211536605666160128151018","article-title":"Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma","volume":"5","author":"Grossi","year":"2016","journal-title":"MicroRNA"},{"key":"32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gdata.2016.06.009","article-title":"MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients","volume":"9","author":"Reid","year":"2016","journal-title":"Genom Data"},{"key":"33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1471-2407-9-441","article-title":"Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma","volume":"9","author":"Tonini","year":"2009","journal-title":"BMC Cancer"},{"key":"34","first-page":"GSE92636","article-title":"Down modulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma","author":"Nadal","year":"2017","journal-title":"Gene Expression Omnibus"},{"key":"35","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","article-title":"miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database","volume":"44","author":"Jian","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene list using DAVID bioinformatics resources","volume":"4","author":"Lempicki","year":"2009","journal-title":"Nat Protoc"},{"key":"37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bdq.2016.05.002","article-title":"Fundamentals of multiplexing with digital PCR","volume":"10","author":"Tzonev","year":"2016","journal-title":"Biomol Detect Quantif"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T16:32:16Z","timestamp":1596731536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":37,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9,15]]}},"alternative-id":["19800","28978143"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19800","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}